Startups channel feed – Endpoints News

Startups channel feed

Salvaging 'ugly fruit': After a series of protein degradation bets, Versant turns to protein stabilization platform out of Columbia

5 years ago

Almost a decade after identifying a new class of RNA, a group of scientists sparks interest from Takeda Ventures

5 years ago

Alloy and Pyxis spin out new 'company' around high-risk I/O, immunology targets

5 years ago

A new RNA startup looks to reimagine heart treatments, with eyes set on Entresto

5 years ago

HIV researcher David Ho has a new line of attack on SARS-CoV-2, and his fledgling startup is gunning for the clinic

5 years ago

Months after Novartis buyout, the old Vedere Bio team is back at it with a new pipeline and a fresh $77M

5 years ago

An OrbiMed-backed startup looks to cut excess corticosteroids with mid-stage tests for its lead drug queued up

5 years ago

Jim Wilson and Tachi Yamada are at it again — launching a 2nd-gen gene therapy company with an appetite for risk, global vision and $200M to gamble with

5 years ago

A T-cell player with backing from Roche takes next big step for BiTE drugs with 'on-off' switch to avoid toxicity

5 years ago

After going down different drug discovery paths, Genentech vets reunite at Foresite Labs to map the 'protein interactome'

5 years ago

A Third Rock-backed player charts a new course against transcription factors. Do 'switch sites' hold the magic sauce?

5 years ago

A non-opioid pain startup believes it can top the bupivacaine market — and it's thinking in terms of weeks, not days

5 years ago

With backing from Bayer, a London firm will pitch its 'hospitals at home' concept for decentralized trials

5 years ago

Can a rare immune cell offer the key to slowing down senescence? A Bay Area startup looks to find out

5 years ago

The incubator that hatched a Jennifer Doudna CRISPR startup blueprints new 'destination for life science entrepreneurship'

5 years ago

The company behind Moderna has a new RNA startup looking to disrupt drugmaking. The goal? 100 new drugs in 10 years

5 years ago

OcuWho? Star dealmaker turned aesthetics czar Brent Saunders flips back into biotech. But who’s he teaming up with now?

5 years ago

Startup sets out to tackle the gene therapy manufacturing crisis

5 years ago

Vik Bajaj's startup incubator at Foresite uncloaks an immunology player with a lead TYK2 inhibitor in tow

5 years ago

'Changing the whole game of drug discovery': Legendary R&D vet Roger Perlmutter leaps back into work as a biotech CEO

5 years ago

Gene therapies in the knee? With the help of a small herd of horses, a new startup hopes to crack osteoarthritis

5 years ago

Josh Bilenker and Jeff Engelman bundle a mother lode of cash for their stealthy startup, attracting a who's who of biotech investors

5 years ago

A new gene therapy player debuts in LA with 2 startup VCs at its back, AbbVie on board with a $90M cash upfront and big plans to upend the field

5 years ago

Exclusive: Ohana, Flagship's big bet on fertility treatments, shuts down and lays off staff after VC pulls the plug

5 years ago

First page Previous page 47 48 495051 52 53 Next page Last page